These Five Stocks Are Trending on Earnings, Analyst Updates
With markets flat after the bell on Wednesday, investors are focused on individual stocks that are reporting their earnings for the previous quarter.
Posts Tagged ‘Synta Pharmaceuticals Corp (SNTA)’
Meridian Bioscience, Inc. (VIVO): Are Hedge Funds Right About This Stock?
In the 21st century investor’s toolkit, there are many methods shareholders can use to track publicly traded companies.
Hedge Funds Are Crazy About IDEXX Laboratories, Inc. (IDXX)
In the 21st century investor’s toolkit, there are dozens of indicators market participants can use to watch the equity markets.
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling
If you were to ask many of your peers, hedge funds are assumed to be overrated, outdated financial vehicles of a forgotten age.
Merrimack Pharmaceuticals Inc (MACK), MannKind Corporation (MNKD), Synta Pharmaceuticals Corp. (SNTA): Horrendous Health-Care Stocks This Week
While the major indexes pulled back this week, their declines paled in comparison to the huge drops experienced by a handful of health-care stocks.
eHealth, Inc. (EHTH), Questcor Pharmaceuticals Inc (QCOR): Three Humongous Health-Care Stocks This Week
How would you like to make a 27%-plus return on your investment -- within one week? Shareholders in three health-care companies enjoyed such gains this week.
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
MannKind Corporation (MNKD) News: FDA Approval, Cloud Hosting & More
With luck, Santa Clarita’s MannKind Corporation (NASDAQ:MNKD) hopes to have FDA approval by April of next year of its innovative diabetes treatment – Afrezza.
Sequenom, Inc. (SQNM), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
This week's list of the most horrendous health-care stocks is brought to you by the letter "S." Just like on Sesame Street, all of the names we will discuss start with the same...
Synta Pharmaceuticals Corp. (SNTA): Under $6 Pharma Stock Gearing Up for a Potential 67% Breakout
Stock picking is both an art and a science. I first started investing in the pre-PC era when information was difficult for the average market player to access.
Calamos Asset Management, Inc (CLMS), Lionbridge Technologies, Inc. (LIOX), Synta Pharmaceuticals Corp. (SNTA): Three Stocks With Heavy Insider Interest
I've come across this asset management firm on several occasions in recent months, as it has appeared on my screens regarding companies with share buybacks, strong free cash...
Abaxis Inc (ABAX): Insiders Aren’t Crazy About It
In today’s marketplace, there are many metrics investors can use to watch stocks. Two of the most under-the-radar are hedge fund and insider trading activity.
Hedge Funds Aren’t Crazy About Quidel Corporation (QDEL) Anymore
In today’s marketplace, there are many indicators shareholders can use to watch the equity markets.
This Metric Says You Are Smart to Buy Trinity Biotech plc (ADR) (TRIB)
If you'd ask most market participants, hedge funds are seen as slow, outdated investment vehicles of years past.
How Are Hedge Funds Trading AMAG Pharmaceuticals, Inc. (AMAG)?
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) the right pick for your portfolio? Prominent investors are taking a pessimistic view.
Is IDEXX Laboratories, Inc. (IDXX) Going to Burn These Hedge Funds?
IDEXX Laboratories, Inc. (NASDAQ:IDXX) was in 11 hedge funds' portfolio at the end of the first quarter of 2013.
Clovis Oncology Inc (CLVS), Synta Pharmaceuticals Corp. (SNTA): Post-ASCO Movers – Are Any a Buy?
Late last year, Clovis Oncology Inc (NASDAQ:CLVS) saw its share price cut in half, to $11.50, after reporting that its Phase 3 drug CO-101 failed to show a benefit over chemotherapy...
Merck & Co., Inc. (MRK), Clovis Oncology Inc (CLVS): All About ASCO – 2013 Highlights
Every week at The Motley Fool we reflect on the top stories in the biotech sector in a wrap-up column.
Rigel Pharmaceuticals, Inc. (RIGL), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
Many stocks encountered turbulence this week, but few were blown about like several biotech stocks.
Synta Pharmaceuticals Corp. (SNTA), VeriFone Systems Inc (PAY): 5 of Last Week’s Biggest Losers
Let's start with Synta Pharmaceuticals Corp. (NASDAQ:SNTA).
Hedge Funds Are Crazy About Synta Pharmaceuticals Corp. (SNTA)
In the eyes of most investors, hedge funds are assumed to be underperforming, old financial vehicles of years past.
Synta Pharmaceuticals Corp. (SNTA): A Promising Biotech Stock for 2013
Biotechnology stocks offer investors some of the highest potential for returns of any industry.
Should You Avoid AMAG Pharmaceuticals, Inc. (AMAG)?
Is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) a good investment today? Investors who are in the know are taking a pessimistic view.
Is Quidel Corporation (QDEL) Going to Burn These Hedge Funds?
To most stock holders, hedge funds are viewed as worthless, old financial tools of years past.
Bristol Myers Squibb Co. (BMY), Amgen, Inc. (AMGN): Tackling Cancer: Melanoma’s Biggest Current & Upcoming Players
As I noted five weeks ago, cancer statistics are both staggering and disappointing.
Why Synta Pharmaceuticals Corp. (SNTA) Shares Stumbled
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
